Zentalis Pharmaceuticals Inc. – Underwriting Agreements Watch

from SCHEDULE 13G Underwriting agreement

from S-3 39 pages Zentalis Pharmaceuticals, Inc. Shares of Common Stock ($0.001 Par Value Per Share) Sales Agreement

from SCHEDULE 13G/A 1 page Whereas, in Accordance With Rule 13d-1(k)(1) Under the Securities and Exchange Act of 1934 (The "Act"), Only One Joint Statement and Any Amendments Thereto Need to Be Filed Whenever One or More Persons Are Required to File Such a Statement or Any Amendments Thereto Pursuant to Section 13(d) of the Act With Respect to the Same Securities, Provided That Said Persons Agree in Writing That Such Statement or Amendments Thereto Is Filed on Behalf of Each of Them; Now, Therefore, the Parties Hereto Agree as Follows

from S-3ASR 39 pages Zentalis Pharmaceuticals, Inc. Shares of Common Stock ($0.001 Par Value Per Share) Sales Agreement

from 8-K 38 pages 11,032,656 Shares Zentalis Pharmaceuticals, Inc. Common Stock (Par Value $0.001 Per Share) Underwriting Agreement June 15, 2023 1

from 8-K 37 pages 10,330,000 Shares Zentalis Pharmaceuticals, Inc. Common Stock (Par Value $0.001 Per Share) Underwriting Agreement May 16, 2022 1

from 8-K 41 pages 3,100,000 Shares Zentalis Pharmaceuticals, Inc. Common Stock (Par Value $0.001 Per Share) Underwriting Agreement

from S-3ASR 39 pages Zentalis Pharmaceuticals, Inc. Shares of Common Stock ($0.001 Par Value Per Share) Sales Agreement

from S-3 39 pages Zentalis Pharmaceuticals, Inc. Shares of Common Stock ($0.001 Par Value Per Share) Sales Agreement

from S-1 41 pages [•] Shares Zentalis Pharmaceuticals, Inc. Common Stock (Par Value $0.001 Per Share) Underwriting Agreement

from S-1/A 45 pages [●] Shares Zentalis Pharmaceuticals, Inc. Common Stock (Par Value $0.001 Per Share) Underwriting Agreement